JPWO2022085622A1 - - Google Patents
Info
- Publication number
- JPWO2022085622A1 JPWO2022085622A1 JP2022557515A JP2022557515A JPWO2022085622A1 JP WO2022085622 A1 JPWO2022085622 A1 JP WO2022085622A1 JP 2022557515 A JP2022557515 A JP 2022557515A JP 2022557515 A JP2022557515 A JP 2022557515A JP WO2022085622 A1 JPWO2022085622 A1 JP WO2022085622A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020177960 | 2020-10-23 | ||
| PCT/JP2021/038408 WO2022085622A1 (ja) | 2020-10-23 | 2021-10-18 | カンナビジオール含有シームレスソフトカプセル |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2022085622A1 true JPWO2022085622A1 (https=) | 2022-04-28 |
Family
ID=81290806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022557515A Pending JPWO2022085622A1 (https=) | 2020-10-23 | 2021-10-18 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230390209A1 (https=) |
| EP (1) | EP4233828A4 (https=) |
| JP (1) | JPWO2022085622A1 (https=) |
| CA (1) | CA3195100A1 (https=) |
| WO (1) | WO2022085622A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024096059A1 (ja) * | 2022-11-01 | 2024-05-10 | 富士カプセル株式会社 | 水封入カプセル及びその製造方法 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002013819A1 (en) * | 2000-08-16 | 2002-02-21 | Chugai Seiyaku Kabushiki Kaisha | Seamless soft capsule preparations containing dihydrobenzofuran derivatives |
| JP2008546400A (ja) * | 2005-06-21 | 2008-12-25 | ヴェ． マヌ フィル | 崩壊可能なカプセルを組み込んだ喫煙器具、崩壊可能なカプセル、及び前記カプセルの製造方法 |
| WO2014171433A1 (ja) * | 2013-04-15 | 2014-10-23 | 三生医薬株式会社 | 崩壊可能なカプセル及びその製造方法並びに崩壊可能なカプセルを含む喫煙器具 |
| CN106943373A (zh) * | 2017-03-22 | 2017-07-14 | 哈尔滨惠美佳生物科技有限公司 | 具有改善糖尿病功效的大麻二酚软胶囊及其制备方法 |
| WO2019135075A1 (en) * | 2018-01-03 | 2019-07-11 | GW Research Limited | Pharmaceutical composition comprising a cannabinoid |
| JP2019123681A (ja) * | 2018-01-15 | 2019-07-25 | 森下仁丹株式会社 | ３−オキソ−４−アザアンドロスト−１−エン−１７−カルボン酸誘導体含有製剤 |
| CN110215443A (zh) * | 2019-07-08 | 2019-09-10 | 云南绿新生物药业有限公司 | 一种抗衰老、改善睡眠软胶囊的制备方法 |
| JP6603817B1 (ja) * | 2019-01-18 | 2019-11-06 | 三生医薬株式会社 | シ−ムレスカプセルならびにこれを含むフィルターおよび喫煙器具 |
| JP2022049575A (ja) * | 2020-09-16 | 2022-03-29 | Ｆｕｔｕｒｅ Ｔｅｃｈｎｏｌｏｇｙ株式会社 | 芳香カートリッジ |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01193216A (ja) * | 1988-01-29 | 1989-08-03 | Fuji Kapuseru Kk | ソフトカプセル及び球状物 |
| DK1361864T3 (en) | 2001-02-14 | 2014-03-03 | Gw Pharma Ltd | FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids |
| GB2414933B (en) | 2004-06-08 | 2009-07-15 | Gw Pharma Ltd | Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis |
| EP1827393A4 (en) * | 2004-12-09 | 2012-04-18 | Insys Therapeutics Inc | AT ROOM TEMPERATURE, STABLE DRONABINOL FORMULATIONS |
| US20070269386A1 (en) * | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
| US8741341B2 (en) * | 2012-05-07 | 2014-06-03 | Insys Therapeutics, Inc. | Manufacturing and packaging room temperature stable dronabinol capsules |
| US20150057342A1 (en) * | 2013-08-21 | 2015-02-26 | Cannabics Pharmaceuticals Inc | Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof |
| US10028919B2 (en) * | 2015-03-10 | 2018-07-24 | Nanosphere Health Sciences, Llc | Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms |
| EP3636253B1 (en) * | 2017-06-09 | 2023-09-13 | Fuji Capsule Co., Ltd. | Seamless capsule shell composition and seamless capsule |
| CA3110786A1 (en) * | 2018-08-27 | 2020-03-05 | Emerald Health Therapeutics Canada Inc. | Therapeutic combinations of boswellia extract and cannabinoids |
| US10925853B2 (en) * | 2019-04-17 | 2021-02-23 | Nordiccan A/S | Oral cannabinoid tablet |
-
2021
- 2021-10-18 US US18/033,005 patent/US20230390209A1/en active Pending
- 2021-10-18 WO PCT/JP2021/038408 patent/WO2022085622A1/ja not_active Ceased
- 2021-10-18 CA CA3195100A patent/CA3195100A1/en active Pending
- 2021-10-18 JP JP2022557515A patent/JPWO2022085622A1/ja active Pending
- 2021-10-18 EP EP21882763.2A patent/EP4233828A4/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002013819A1 (en) * | 2000-08-16 | 2002-02-21 | Chugai Seiyaku Kabushiki Kaisha | Seamless soft capsule preparations containing dihydrobenzofuran derivatives |
| JP2008546400A (ja) * | 2005-06-21 | 2008-12-25 | ヴェ． マヌ フィル | 崩壊可能なカプセルを組み込んだ喫煙器具、崩壊可能なカプセル、及び前記カプセルの製造方法 |
| WO2014171433A1 (ja) * | 2013-04-15 | 2014-10-23 | 三生医薬株式会社 | 崩壊可能なカプセル及びその製造方法並びに崩壊可能なカプセルを含む喫煙器具 |
| CN106943373A (zh) * | 2017-03-22 | 2017-07-14 | 哈尔滨惠美佳生物科技有限公司 | 具有改善糖尿病功效的大麻二酚软胶囊及其制备方法 |
| WO2019135075A1 (en) * | 2018-01-03 | 2019-07-11 | GW Research Limited | Pharmaceutical composition comprising a cannabinoid |
| JP2019123681A (ja) * | 2018-01-15 | 2019-07-25 | 森下仁丹株式会社 | ３−オキソ−４−アザアンドロスト−１−エン−１７−カルボン酸誘導体含有製剤 |
| JP6603817B1 (ja) * | 2019-01-18 | 2019-11-06 | 三生医薬株式会社 | シ−ムレスカプセルならびにこれを含むフィルターおよび喫煙器具 |
| CN110215443A (zh) * | 2019-07-08 | 2019-09-10 | 云南绿新生物药业有限公司 | 一种抗衰老、改善睡眠软胶囊的制备方法 |
| JP2022049575A (ja) * | 2020-09-16 | 2022-03-29 | Ｆｕｔｕｒｅ Ｔｅｃｈｎｏｌｏｇｙ株式会社 | 芳香カートリッジ |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022085622A1 (ja) | 2022-04-28 |
| EP4233828A4 (en) | 2024-09-04 |
| CA3195100A1 (en) | 2022-04-28 |
| EP4233828A1 (en) | 2023-08-30 |
| US20230390209A1 (en) | 2023-12-07 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230406 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240909 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251110 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251219 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20251219 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260327 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260417 |